Morphologic Aspects of Interstitial Pneumonia With Autoimmune Features

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
COLL AMER PATHOLOGISTS
Citação
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, v.142, n.9, p.1080-1089, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Context.-Interstitial lung disease, a common complication observed in several connective tissue diseases, causes significant morbidity and mortality. Similar to individuals with connective tissue diseases, a significant subgroup of patients with clinical and serologic characteristics suggestive of autoimmunity but without confirmed specific connective tissue disease presents with associated interstitial lung disease. These patients have been classified using different controversial nomenclatures, such as undifferentiated connective tissue disease-associated interstitial lung disease, lung-dominant connective tissue disease, and autoimmune featured interstitial lung disease. The need for a better understanding and standardization of this entity, interstitial lung disease with autoimmune features, and the need for an adequate management protocol for patients resulted in the introduction of a new terminology in 2015: interstitial pneumonia with autoimmune features. This new classification requires a better comprehension of its diagnostic impact and the influence of its morphologic aspects on the prognosis of patients. Objective.-To review the diagnostic criteria for interstitial pneumonia with autoimmune features, with an emphasis on morphologic aspects. Data Sources.-The review is based on the available literature, and on pathologic, radiologic, and clinical experience. Conclusions.-The interstitial pneumonia with autoimmune features classification seems to identify a distinct subgroup of patients with different prognoses. Studies show that nonspecific interstitial pneumonia and usual interstitial pneumonia are the most prevalent morphologic patterns and show discrepant results on the impact of the usual interstitial pneumonia pattern on survival. Prospective investigations are necessary to better define this subgroup and to determine the prognosis and appropriate clinical management of these patients.
Palavras-chave
Referências
  1. Adegunsoye A, 2017, ARCH PATHOL LAB MED, V141, P960, DOI 10.5858/arpa.2016-0427-OA
  2. Adegunsoye A, 2016, RESP MED, V114, P53, DOI 10.1016/j.rmed.2016.03.012
  3. Ahmad K, 2017, RESP MED, V123, P56, DOI 10.1016/j.rmed.2016.10.017
  4. Alhamad EH, 2013, ANN THORAC MED, V8, P33, DOI 10.4103/1817-1737.105717
  5. Assayag D, 2015, RESP MED, V109, P1326, DOI 10.1016/j.rmed.2015.08.010
  6. Bauer PR, 2015, RESP MED, V109, P397, DOI 10.1016/j.rmed.2015.01.011
  7. Chartrand S, 2016, RESP MED, V119, P150, DOI 10.1016/j.rmed.2016.09.002
  8. Chung JH, 2017, AM J ROENTGENOL, V208, P1229, DOI 10.2214/AJR.16.17121
  9. Collins BF, 2017, CHEST, V152, P103, DOI 10.1016/j.chest.2017.03.004
  10. Cottin V, 2016, RESPIROLOGY, V21, P245, DOI 10.1111/resp.12588
  11. de Lauretis A, 2011, CHRON RESP DIS, V8, P53, DOI 10.1177/1479972310393758
  12. Ferri C, 2016, AUTOIMMUN REV, V15, P61, DOI 10.1016/j.autrev.2015.09.003
  13. Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015
  14. Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194
  15. Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC
  16. Hu Y, 2016, CHEST, V149, P201, DOI 10.1378/chest.15-1145
  17. Jee AS, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050051
  18. Karakatsani A, 2009, RESP MED, V103, P1122, DOI 10.1016/j.rmed.2009.03.001
  19. Katzenstein ALA, 2006, KATZENSTEIN ASKINS S, V13
  20. Kawano-Dourado L, 2013, CLIN EXP RHEUMATOL, V31, P950
  21. Kim HC, 2015, CHEST, V147, P165, DOI 10.1378/chest.14-0272
  22. Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC
  23. Kono M, 2016, RESP MED, V117, P40, DOI 10.1016/j.rmed.2016.05.030
  24. Larsen BT, 2012, ARCH PATHOL LAB MED, V136, P1234, DOI 10.5858/arpa.2012-0225-RA
  25. Lettieri CJ, 2005, RESP MED, V99, P1425, DOI 10.1016/j.rmed.2005.03.008
  26. Luppi F, 2016, EUR RESPIR J, V47, P1622, DOI 10.1183/13993003.00690-2016
  27. Monaghan H, 2004, CHEST, V125, P522, DOI 10.1378/chest.125.2.522
  28. Mosca M, 2014, J AUTOIMMUN, V48-49, P50, DOI 10.1016/j.jaut.2014.01.019
  29. Oldham JM, 2016, EUR RESPIR J, V47, P1767, DOI 10.1183/13993003.01565-2015
  30. Omote N, 2015, CHEST, V148, P1438, DOI 10.1378/chest.14-3174
  31. Prasad JD, 2017, RESPIROLOGY, V22, P1459, DOI 10.1111/resp.13163
  32. Romagnoli M, 2011, EUR RESPIR J, V38, P384, DOI 10.1183/09031936.00094910
  33. Pereira DAS, 2015, J BRAS PNEUMOL, V41, P151, DOI 10.1590/S1806-37132015000004443
  34. Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572
  35. Suda T, 2015, CLIN MED INSIGHTS-CI, V9, P155, DOI [10.4137/CCRPRPM.S23289, 10.4137/CCRPM.S23289]
  36. Suda T, 2010, RESP MED, V104, P1527, DOI 10.1016/j.rmed.2010.04.022
  37. Tansey D, 2004, HISTOPATHOLOGY, V44, P585, DOI 10.1111/j.1365-2559.2004.01896.x
  38. Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662